-
German factory orders rise at fastest rate in 2 years in December
-
Nigeria president deploys army after new massacre
-
Ukraine, Russia, US start second day of war talks
-
Nepal's youth lead the charge in the upcoming election
-
Sony hikes forecasts even as PlayStation falters
-
Rijksmuseum puts the spotlight on Roman poet's epic
-
Trump fuels EU push to cut cord with US tech
-
Fearless talent: Five young players to watch at the T20 World Cup
-
India favourites as T20 World Cup to begin after chaotic build-up
-
Voter swings raise midterm alarm bells for Trump's Republicans
-
Australia dodges call for arrest of visiting Israel president
-
Countries using internet blackouts to boost censorship: Proton
-
Top US news anchor pleads with kidnappers for mom's life
-
Thailand's pilot PM on course to keep top job
-
The coming end of ISS, symbol of an era of global cooperation
-
New crew set to launch for ISS after medical evacuation
-
Family affair: Thailand waning dynasty still election kingmaker
-
Japan's first woman PM tipped for thumping election win
-
Stocks in retreat as traders reconsider tech investment
-
LA officials call for Olympic chief to resign over Epstein file emails
-
Ukraine, Russia, US to start second day of war talks
-
Fiji football legend returns home to captain first pro club
-
Trump attacks US electoral system with call to 'nationalize' voting
-
Barry Manilow cancels Las Vegas shows but 'doing great' post-surgery
-
US households become increasingly strained in diverging economy
-
Four dead men: the cold case that engulfed a Colombian cycling star
-
Super Bowl stars stake claims for Olympic flag football
-
On a roll, Brazilian cinema seizes its moment
-
Rising euro, falling inflation in focus at ECB meeting
-
AI to track icebergs adrift at sea in boon for science
-
Indigenous Brazilians protest Amazon river dredging for grain exports
-
Google's annual revenue tops $400 bn for first time, AI investments rise
-
Last US-Russia nuclear treaty ends in 'grave moment' for world
-
BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
-
Man City brush aside Newcastle to reach League Cup final
-
Guardiola wants permission for Guehi to play in League Cup final
-
Boxer Khelif reveals 'hormone treatments' before Paris Olympics
-
'Bad Boy,' 'Little Pablo' and Mordisco: the men on a US-Colombia hitlist
-
BHP damages trial over Brazil mine disaster to open in 2027
-
Dallas deals Davis to Wizards in blockbuster NBA trade: report
-
Iran-US talks back on, as Trump warns supreme leader
-
Lens cruise into French Cup quarters, Endrick sends Lyon through
-
No.1 Scheffler excited for Koepka return from LIV Golf
-
Curling quietly kicks off sports programme at 2026 Winter Olympics
-
Undav pokes Stuttgart past Kiel into German Cup semis
-
Germany goalkeeper Ter Stegen to undergo surgery
-
Bezos-led Washington Post announces 'painful' job cuts
-
Iran says US talks are on, as Trump warns supreme leader
-
Gaza health officials say strikes kill 24 after Israel says officer wounded
-
Empress's crown dropped in Louvre heist to be fully restored: museum
Most long Covid symptoms clear up in a year for mild cases: study
Most symptoms from long Covid clear up within a year for people who had mild initial infections, a large Israel study said Thursday, with the findings welcomed as "reassuring".
At least 17 million people in Europe suffered from long Covid symptoms months after recovering from their initial infection during 2020 and 2021, according to modelling from the World Health Organization.
However much about the condition has remained unclear, including how long it lasts.
Researchers in Israel analysed the medical records of nearly two million people of all ages who were tested for Covid in the country between March 2020 and October 2021.
The results therefore covered the earlier Covid variants including Delta, but not the more recently discovered Omicron variants.
The researchers combed through the records, which were provided by Maccabi Healthcare Services, for more than 70 different symptoms that have been linked to long Covid.
They excluded patients who had more serious illness, including those who were hospitalised, which previous research has suggested have a higher risk of long Covid.
For the mild cases, the study found a significantly increased risk of several conditions, including loss of smell and taste, breathing problems, weakness, palpitations, strep throat, dizziness, and concentration and memory impairment commonly called "brain fog".
However most symptoms cleared up within 12 months.
"There is a small number of people still suffering from shortness of breath or weakness for a year after Covid," said Maytal Bivas-Benita, a researcher at Israel's KI Research Institute and study co-author.
The study, published in the journal BMJ, also found that vaccinated patients had a lower risk of breathing problems -- the most common symptom -- compared to unvaccinated cases.
Children meanwhile had fewer health problems than adults, and recovered from most of them well within a year.
Bivas-Benita told AFP that she was "encouraged" by the findings, particularly after fears about how long the symptoms could linger.
"The vast majority of patients will be OK after a year," she said.
Lead study author Barak Mizrahi said he hoped the research would help lower uncertainty for doctors trying to figure out if their patients' symptoms are related to Covid.
Michael Absoud, a paediatrician and clinical academic at King's College London not involved in the study, called the findings "reassuring".
It confirms that the vast majority of children with long Covid symptoms have "a very good recovery," he said.
J.Horn--BTB